The expression of PKM2 is upregulated in HSC in the context of liver fibrosis and is overexpressed in hepatic macrophages and Th17 cells during NAFLD/NASH development [40,41,42]. This evidence concerns the gene PKM and metabolic dysfunction-associated steatohepatitis.